HOME    | Hepatitis B     | Hepatitis C  
<--- Return to the 56th AASLD Main Page
HIVandHepatitis.com Coverage of Highlights from the
56th Annual Meeting of the American
Association for the Study of Liver Diseases
 November 11 - 15, 2005 San Francisco, California


Sustained Virologic Response (SVR)

Treatment of Genotype 1 Chronic Hepatitis C: Increased Sustained Virological Response with High-dose RBV and Epoetin - 11/23/05

Does Weight-based Ribavirin Dosing Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study - 11/18/05

Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Patients Not Responding to Prior Peginterferon Alfa-2b (PegIntron)/ Ribavirin Combination Therapy-The REPEAT Study - 11/14/05

Pegetron Prospective Optimal Weight-based Dosing Response Program (POWeR): Preliminary Results - 11/14/05

Efficacy of Peginterferon Alfa-2b (PegIntron) vs. Peginterferon Alfa-2a (Pegasys) Plus Ribavirin Regimens in Treatment-naïve Chronic HCV Patients: A Meta-analysis - 11/14/05

Consensus Interferon in Combination with Gamma Interferon and/or Ribavirin Results in a Significant Virologic Response in Hepatitis C Genotype 1 Patients - 11/14/05



<--- Return to the 56th AASLD Main Page